|
Real-time Estimate
Cboe BZX
17:47:44 13/05/2026 BST
|
5-day change
|
1st Jan Change
|
|
119.78 USD
|
-0.73%
|
|
-7.88%
|
+22.69%
|
| 03:11pm |
BofA Securities Raises Target's Price Target to $110 From $106, Underperform Rating Kept
|
MT
| | 03:10pm |
Truist Lifts Price Target on Target to $123 From $121, Keeps Hold Rating
|
MT
| |
05-12 |
Target Likely to Post Strong First-Quarter Comparable Sales Growth, UBS Says
|
MT
| |
05-12 |
Target Q1 Results Set to Validate Turnaround Momentum, UBS Says
|
MT
| |
05-12 |
Wells Fargo Adjusts Price Target on Target to $140 From $135, Maintains Overweight Rating
|
MT
| |
05-11 |
Barclays Adjusts Target's Price Target to $115 From $108
|
MT
| |
05-08 |
RBC Raises Price Target on Target to $132 From $130, Keeps Outperform Rating
|
MT
| |
05-05 |
Target Has Potential to Beat Analyst Expectations in Q1, Oppenheimer Says
|
MT
| |
05-05 |
Citigroup Adjusts Price Target on Target to $133 From $117, Maintains Neutral Rating
|
MT
| |
04-24 |
Bernstein Adjusts Price Target on Target to $124 From $116, Maintains Market Perform Rating
|
MT
| |
04-21 |
Evercore ISI Adjusts Target's Price Target to $125 From $120, Maintains In Line Rating
|
MT
| |
04-20 |
Guggenheim Adjusts Price Target on Target to $140 From $130, Maintains Buy Rating
|
MT
| |
03-20 |
TD Cowen Adjusts Price Target on Target to $130 From $135, Maintains Hold Rating
|
MT
| |
03-10 |
DA Davidson Adjusts Price Target on Target to $140 From $120, Maintains Buy Rating
|
MT
| |
03-06 |
Argus Research Adjusts Target PT to $145 From $125, Maintains Buy Rating
|
MT
| |
03-06 |
Daiwa Securities Adjusts Price Target on Target to $118 From $86, Maintains Neutral Rating
|
MT
| |
03-05 |
Evercore ISI Adjusts Price Target on Target to $120 From $105, Maintains In Line Rating
|
MT
| |
03-05 |
JPMorgan Adjusts Price Target on Target to $120 From $115, Maintains Neutral Rating
|
MT
| |
03-04 |
UBS Adjusts Target's Price Target to $144 From $130, Maintains Buy Rating
|
MT
| |
03-04 |
Target's Prospects Likely to Improve as Turnaround Efforts Take Shape, Oppenheimer Says
|
MT
| |
03-04 |
Target's $2 Billion Investment Plan Key to Reigniting Topline Growth, Morgan Stanley Says
|
MT
| |
03-04 |
Oppenheimer Adjusts Target PT to $140 From $130, Maintains Outperform Rating
|
MT
| |
03-04 |
BofA Securities Adjusts Price Target on Target to $106 From $103, Maintains Underperform Rating
|
MT
| |
03-04 |
Truist Raises Price Target on Target to $121 From $90, Keeps Hold Rating
|
MT
| |
03-04 |
TD Cowen Adjusts Price Target on Target to $135 From $100, Maintains Hold Rating
|
MT
|
No results for this search
Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
|